NEW YORK, September 24 /PRNewswire/ --

- Liberty Interoperable Event Features Full-Matrix and eGovernment Profile Testing as Global Demand for Interoperable Identity Solutions Continues to Grow

AUBURN HILLS, Michigan, September 23 /PRNewswire/ --

- Company Introduces Three Advanced Electric-Drive Vehicle Prototypes

Actions speak louder than words.

LONDON, September 23 /PRNewswire/ --

As energy costs rise and the need to reduce carbon emissions grows, many businesses are looking to their facilities managers to cut energy use and create a more sustainable business model. Greater public scrutiny is making environmental performance almost as important as financial performance in today's business climate.

LONDON, September 23 /PRNewswire/ -- Following Prime Minister Gordon Brown's speech today at the Labour party conference, the MS Society welcomes news of a commitment to end prescription charges for people with long-term conditions.

Speaking at the conference in Manchester, Mr Gordon Brown said: "....so our plan is next year to abolish all prescription charges for everyone with cancer. And this is not the limit of our commitment to a fair NHS. In the long term, the NHS generates cash savings in its budget we will plough savings back into abolishing charges for all patients with long-term conditions."

LONDON, September 23 /PRNewswire/ --

The Georgian National Communications Commission (GNCC) announced a fine of more than US$360,000 against the Russian telecom company Megafon for operating without a license within Georgian territory. Officials claim that despite previous administrative sanctions against Megafon, the company persists in illegal use of the Georgian radiofrequency spectrum to provide mobile telecommunications services.

LONDON, September 23 /PRNewswire/ -- Commenting on the promise to abolish prescription charges for cancer patients, the Chair of the English Pharmacy Board of the Royal Pharmaceutical Society of Great Britain, Beth Taylor said:

"This is good news for those affected by cancer. It is unfair for cancer patients to have to deal with the added financial burden of prescription charges and we see at first hand the anguish that this can cause.